Renewing Rinvoq (Upadacitinib) Approval with Cigna in Washington: Complete Timeline and Documentation Guide
Answer Box: Renewing Rinvoq with Cigna in Washington
Cigna requires annual reauthorization for Rinvoq (upadacitinib) with documented clinical improvement and ongoing specialist oversight. Submit renewal 30-60 days before expiration with objective response measures (labs, symptom scores) and current monitoring results. If denied, Washington residents have 180 days for internal appeals